List of Excipients in API REGADENOSON
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing REGADENOSON
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hospira Inc | regadenoson | 0409-1401 | EDETATE DISODIUM |
Hospira Inc | regadenoson | 0409-1401 | PROPYLENE GLYCOL |
Hospira Inc | regadenoson | 0409-1401 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
Hospira Inc | regadenoson | 0409-1401 | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for REGADENOSON
Excipient focus: EDETATE DISODIUM
REGADENOSON drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
REGADENOSON drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE
REGADENOSON drug variants containing SODIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing SODIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
Eugia US LLC | regadenoson | 55150-443 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
REGADENOSON drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
International Medication Systems Limited | regadenoson | 76329-3321 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
Eugia US LLC | regadenoson | 55150-443 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
REGADENOSON drug variants containing SODIUM PHOSPHATE, DIBASIC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing SODIUM PHOSPHATE, DIBASIC
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
Eugia US LLC | regadenoson | 55150-443 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
REGADENOSON drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Meitheal Pharmaceuticals Inc | regadenoson | 71288-201 |
International Medication Systems Limited | regadenoson | 76329-3321 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
Eugia US LLC | regadenoson | 55150-443 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
REGADENOSON drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
Eugia US LLC | regadenoson | 55150-443 |
Apotex Corp | regadenoson | 60505-6116 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
Meitheal Pharmaceuticals Inc | regadenoson | 71288-201 |
International Medication Systems Limited | regadenoson | 76329-3321 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
REGADENOSON drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
Eugia US LLC | regadenoson | 55150-443 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
REGADENOSON drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | regadenoson | 0409-1401 |
Hikma Pharmaceuticals USA Inc | regadenoson | 0641-6253 |
Baxter Healthcare Corporation | regadenoson | 36000-364 |
Dr Reddy's Laboratories Inc | regadenoson | 43598-616 |
>Company | >Ingredient | >NDC |
REGADENOSON drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Mylan Institutional LLC | regadenoson | 67457-994 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.